Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2002
11/21/2002DE10123503A1 Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia
11/21/2002CA2460603A1 Unigene unidirectional antisense library
11/21/2002CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002CA2447292A1 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002CA2447286A1 Random gene unidirectional antisense library
11/21/2002CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002CA2445922A1 Estrogen receptor modulators
11/21/2002CA2445366A1 Molecules for disease detection and treatment
11/21/2002CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002EP1258484A1 Novel isoxazole and thiazole compounds and use thereof as drugs
11/20/2002EP1258474A2 Alkylamide compounds
11/20/2002EP1258253A1 Novel remedies with the use of beta3 agonist
11/20/2002EP1257646A2 Transporters and ion channels
11/20/2002EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002EP1257554A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments
11/20/2002EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002EP1257546A1 Kinase inhibitors
11/20/2002EP1257543A1 Pyridinylimidazoles
11/20/2002EP1257528A1 Aminoalcohol derivatives
11/20/2002EP1257277A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
11/20/2002EP1257264A1 Estrogen receptor modulators
11/20/2002EP1150969B1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
11/20/2002EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002CN1094347C Release-controlled micropill for treating benign prostatic hyperplasis and its preparing method
11/19/2002US6482956 Endothelin receptor antagonists
11/19/2002US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002CA2219502C Methods and formulations for modulating the human sexual response
11/19/2002CA2092821C Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organs
11/19/2002CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/18/2002CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/14/2002WO2002090530A2 Kinases and phosphatases
11/14/2002WO2002090387A1 Reproductive cancer diagnosis and therapy
11/14/2002WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002WO2002090355A1 N-aroyl cyclic amines
11/14/2002WO2002090353A1 Sulfonamides
11/14/2002WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090337A1 Sulfonamides
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090025A1 Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application
11/14/2002WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002WO2002089831A1 Preventives/remedies for nephritis
11/14/2002WO2002089816A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
11/14/2002WO2002089809A1 Medicinal uses of hydrazones and hydrazines
11/14/2002WO2002089802A2 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
11/14/2002WO2002089801A1 Use of benzothiophenes to treat and prevent prostave cancer
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002089787A1 Potentiation of therapeutic effects of fatty acids
11/14/2002WO2002089785A1 Sulfonamides
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002WO2002089740A2 Sulfonamides
11/14/2002WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002WO2002049634A3 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
11/14/2002WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002US20020169317 Oxazinocarbazoles for the treatment of CNS diseases
11/14/2002US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002US20020169213 Outstanding agonistic effect on alpha-1L-receptors; highly selective on the contractile mechanisms of the bladder without affecting other organs e.g., peripheral blood vessels; particularly incontinence due to stress
11/14/2002US20020169209 Potentiation of therapeutic effects of fatty acids
11/14/2002US20020169208 Oxybutynin analogs; antichloinergic agents; side effect reduction; short half-life; water-soluble metabolites; incontinence; mydriatic and bronchodilator agents; respiratory system disorders; antiperspirants
11/14/2002US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002US20020169202 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
11/14/2002US20020169198 Agonists of the progesterone receptor; contraceptives, hormone replacement therapy and treating menopause symptoms
11/14/2002US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof
11/14/2002US20020169174 Xanthine phosphodiesterase V inhibitors
11/14/2002US20020169171 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
11/14/2002US20020169169 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
11/14/2002US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002US20020169163 1,2,3,4-tetrahydro-pyrazino(1,2-a)indole derivatives useful in treating obesity, central nerveous system diosrders, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, type II diabetes, obesity and sleep apnoea
11/14/2002US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002US20020169152 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
11/14/2002US20020169150 Hormone replacement therapy
11/14/2002US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002US20020169128 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
11/14/2002US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002US20020168650 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/14/2002US20020168434 Cyclooxygenase inhibitor; anticancer agents, Alzheimer's disease, central nervous system disorders
11/14/2002US20020168358 Modulating the binding of the particular chemokines SLC (secondary lymphoid chemokine), and MIP-3b (macrophage inflammatory protein-3b), to immune system T-cells and dendritic cells to treat adverse inflammatory responses etc
11/14/2002US20020168344 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
11/14/2002DE10119680A1 Verwendung von Radikalfänger-Verbindungen zur Behandlung und Verhinderung von no-abhängigen Störungen der Mikrozirkulation Use of scavenger compounds for the treatment and prevention of no-dependent disorders of microcirculation
11/14/2002CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002CA2446857A1 Reproductive cancer diagnosis and therapy
1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 562